Join a New Dawn for the Peptide Field!
Returning to Boston this summer, the 2nd Peptide Formulation & Delivery Innovation Summit was your industry-dedicated forum, focused on pursuing state-of-the-art peptide pharmaceutical formulation approaches and innovative peptide delivery systems.Â
This was your chance to meet over 70 senior-level peptide experts working in solid and liquid dose formulations, peptide drug product formulation, advanced drug delivery, CMC, safety, clinical development, and more. They were sharing industry cross-learnings about the latest formulation and delivery technologies that will advance novel peptide-based drug products towards the clinic and into market.Â
Highlights You Missed:
Predicting the translatability of discovery and preclinical systems into humans to accelerate peptides into the clinic with Eli LillyÂ
Exploring innovative technologies and advanced formulations for oral delivery to achieve double-digit peptide bioavailability with AnaBio Technologies, Divincell, and Aviceda TherapeuticsÂ
Discussing the considerations for high-concentration SC or multi-dose peptide injectables as well as analytical development challenges with Novo Nordisk, and the University of MiamiÂ
Pushing the limits of peptide formulation through inhaled and intradermal to maximize pan-disease applications with Neurelis, and Carocell BioÂ
Learning about peptide formulation and delivery considerations from biotech companies in the clinic with Xeris Pharmaceuticals, and Lyndra Therapeutics
Who Attended?
What Your Peers Had to Say
